XCUR
XCUR
NASDAQ · Biotechnology

Exicure Inc

$4.03
-0.23 (-5.40%)
As of Feb 8, 2:21 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +664.8% upside
Low Target $21.30
Average Target $30.82
High Target $34.43
Current Price $4.03
Current
$4.03
Target
$30.82
$21.30 $30.82 avg $34.43
Scenario Analysis
Bear Case
$21.30
428.5%
Low target
Base Case
$30.82
+664.8%
Avg target
Bull Case
$34.43
+754.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$32.34
-87.5% from high
52-Week Low
$13.36
+-69.8% from low
Target vs 52W High
$30.82
-4.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%